Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Medical Imaging
  4. Volume 20, Issue 1
  5. Article
Volume 20, Issue 1
  • ISSN: 1573-4056
  • E-ISSN: 1875-6603
file format pdf download PDF
side by side viewer icon HTML

Abstract

Background

Despite the availability of vaccines, there is an increasing number of SARS-CoV-2-breakthrough-infections.

Objective

The aim of this study was to determine whether there is a radiological difference in lung parenchymal involvement between infected vaccinated and unvaccinated patients. Additionally, we aimed to investigate whether vaccination has an impact on the course of illness and the need for intensive care.

Methods

This study includes all patients undergoing chest computed tomography (CT) or x-ray imaging in case of a proven SARS-CoV-2 infection between September and November 2021. Anonymized CT and x-ray images were reviewed retrospectively and in consensus by two radiologists, applying an internal severity score scheme for CT and x-ray as well as CARE and BRIXIA scores for x-ray. Radiological findings were compared to vaccination status, comorbidities, inpatient course of the patient’s illness and the subjective onset of symptoms.

Results

In total, 38 patients with acute SARS-CoV-2 infection underwent a CT scan, and 168 patients underwent an x-ray examination during the study period. Of these, 32% were vaccinated in the CT group, and 45% in the x-ray group. For the latter, vaccinated patients exhibited significantly more comorbidities (cardiovascular (p=0.002), haemato-oncological diseases (p=0.016), immunosuppression (p=0.004)), and a higher age (p<0.001). Vaccinated groups showed significantly lower extent of lung involvement (severity scores in CT cohort and x-ray cohort both p≤0.020; ARDS 42% in unvaccinated CT cohort . 8% in vaccinated CT cohort). Furthermore, vaccinated patients in the CT cohort had significantly less need for intensive care treatment (p=0.040).

Conclusion

Our data suggest that vaccination, in the case of breakthrough infection, favours a milder course of illness concerning lung parenchymal involvement and the need for intensive care, despite negative predictors, such as immunosuppression or other pre-existing conditions.

© 2024 The Author(s). Published by Bentham Science Publisher.
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cmir/10.2174/0115734056282920231212104602
2024-01-01
2025-05-29

  • From This Site

    /content/journals/cmir/10.2174/0115734056282920231212104602
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
The full text of this item is not currently available.

References

  1. World Health OrganizationWHO Coronavirus (COVID-19) Dashboard.2023Available from:https://covid19.who.int/ (Accessed on: 2023-11-27).
  2. De SmetK. De SmetD. RyckaertT. LaridonE. HeremansB. VandenbulckeR. DemedtsI. BouckaertB. GryspeerdtS. MartensG.A. Diagnostic performance of chest CT for SARS-CoV-2 infection in individuals with or without COVID-19 symptoms.Radiology20212981E30E3710.1148/radiol.202020270832776832
     [Google Scholar]
  3. SchalekampS. Bleeker-RoversC.P. BeenenL.F.M. Quarles van UffordH.M.E. GietemaH.A. StögerJ.L. HarrisV. ReijersM.H.E. Rahamat-LangendoenJ. KorevaarD.A. SmitsL.P. KortewegC. van Rees VellingaT.F.D. VermaatM. StassenP.M. ScheperH. WijnakkerR. BormF.J. DofferhoffA.S.M. ProkopM. Chest CT in the emergency department for diagnosis of COVID-19 pneumonia: Dutch experience.Radiology20212982E98E10610.1148/radiol.202020346533201791
     [Google Scholar]
  4. BergwerkM. GonenT. LustigY. AmitS. LipsitchM. CohenC. MandelboimM. LevinE.G. RubinC. IndenbaumV. TalI. ZavitanM. ZuckermanN. Bar-ChaimA. KreissY. Regev-YochayG. Covid-19 breakthrough infections in vaccinated health care workers.N. Engl. J. Med.2021385161474148410.1056/NEJMoa210907234320281
     [Google Scholar]
  5. RubinG.D. RyersonC.J. HaramatiL.B. SverzellatiN. KanneJ.P. RaoofS. SchlugerN.W. VolpiA. YimJ.J. MartinI.B.K. AndersonD.J. KongC. AltesT. BushA. DesaiS.R. GoldinJ. GooJ.M. HumbertM. InoueY. KauczorH.U. LuoF. MazzoneP.J. ProkopM. Remy-JardinM. RicheldiL. Schaefer-ProkopC.M. TomiyamaN. WellsA.U. LeungA.N. The role of chest imaging in patient management during the COVID-19 pandemic.Chest2020158110611610.1016/j.chest.2020.04.00332275978
     [Google Scholar]
  6. ProkopM. van EverdingenW. van Rees VellingaT. Quarles van UffordH. StögerL. BeenenL. GeurtsB. GietemaH. KrdzalicJ. Schaefer-ProkopC. van GinnekenB. BrinkM. CO-RADS: A categorical ct assessment scheme for patients suspected of having covid-19-definition and evaluation.Radiology20202962E97E10410.1148/radiol.202020147332339082
     [Google Scholar]
  7. WangD. ShangY. ChenY. XiaJ. TianW. ZhangT. DaiH. LiY. Clinical value of COVID-19 chest radiography and high-resolution CT examination.Curr. Med. Imaging Rev.202218778078610.2174/157340561866621122914312134967290
     [Google Scholar]
  8. RevelM.P. ParkarA.P. ProschH. SilvaM. SverzellatiN. GleesonF. BradyA. COVID-19 patients and the radiology department – advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI).Eur. Radiol.20203094903490910.1007/s00330‑020‑06865‑y32314058
     [Google Scholar]
  9. LiuD. FuF. YeA. QiaoZ. HuC. ChestC.T. Chest CT features of patients with COVID-19 pneumonia following hospital discharge.Curr. Med. Imaging Rev.202319890090636624646
     [Google Scholar]
  10. Gallo MarinB. AghagoliG. LavineK. YangL. SiffE.J. ChiangS.S. Salazar-MatherT.P. DumencoL. SavariaM.C. AungS.N. FlaniganT. MichelowI.C. Predictors of COVID-19 severity: A literature review.Rev. Med. Virol.202131111010.1002/rmv.214632845042
     [Google Scholar]
  11. HaasE.J. AnguloF.J. McLaughlinJ.M. AnisE. SingerS.R. KhanF. BrooksN. SmajaM. MircusG. PanK. SouthernJ. SwerdlowD.L. JodarL. LevyY. Alroy-PreisS. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: An observational study using national surveillance data.Lancet2021397102871819182910.1016/S0140‑6736(21)00947‑833964222
     [Google Scholar]
  12. ScobieH.M. JohnsonA.G. SutharA.B. SeversonR. AldenN.B. BalterS. BertolinoD. BlytheD. BradyS. CadwellB. ChengI. DavidsonS. DelgadilloJ. DevinneyK. DuchinJ. DuwellM. FisherR. FleischauerA. GrantA. GriffinJ. HaddixM. HandJ. HansonM. HawkinsE. HerlihyR.K. HicksL. HoltzmanC. HoskinsM. HyunJ. KaurR. KayM. KidrowskiH. KimC. KomatsuK. KugelerK. LewisM. LyonsB.C. LyonsS. LynfieldR. McCaffreyK. McMullenC. MilroyL. MeyerS. NolenL. PatelM.R. PogosjansS. ReeseH.E. SaupeA. SellJ. SokolT. SosinD. StanislawskiE. StevensK. VestH. WhiteK. WilsonE. MacNeilA. RitcheyM.D. SilkB.J. Monitoring incidence of COVID-19 cases, hospitalizations, and deaths, by vaccination status — 13 U.S. Jurisdictions, April 4–July 17, 2021.MMWR Morb. Mortal. Wkly. Rep.202170371284129010.15585/mmwr.mm7037e134529637
     [Google Scholar]
  13. ClemA. Fundamentals of vaccine immunology.J. Glob. Infect. Dis.201131737810.4103/0974‑777X.7729921572612
     [Google Scholar]
  14. PolackF.P. ThomasS.J. KitchinN. AbsalonJ. GurtmanA. LockhartS. PerezJ.L. Pérez MarcG. MoreiraE.D. ZerbiniC. BaileyR. SwansonK.A. RoychoudhuryS. KouryK. LiP. KalinaW.V. CooperD. FrenckR.W.Jr HammittL.L. TüreciÖ. NellH. SchaeferA. ÜnalS. TresnanD.B. MatherS. DormitzerP.R. ŞahinU. JansenK.U. GruberW.C. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine.N. Engl. J. Med.2020383272603261510.1056/NEJMoa203457733301246
     [Google Scholar]
  15. BadenL.R. El SahlyH.M. EssinkB. KotloffK. FreyS. NovakR. DiemertD. SpectorS.A. RouphaelN. CreechC.B. McGettiganJ. KhetanS. SegallN. SolisJ. BroszA. FierroC. SchwartzH. NeuzilK. CoreyL. GilbertP. JanesH. FollmannD. MarovichM. MascolaJ. PolakowskiL. LedgerwoodJ. GrahamB.S. BennettH. PajonR. KnightlyC. LeavB. DengW. ZhouH. HanS. IvarssonM. MillerJ. ZaksT. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.N. Engl. J. Med.2021384540341610.1056/NEJMoa203538933378609
     [Google Scholar]
  16. VoyseyM. ClemensS.A.C. MadhiS.A. WeckxL.Y. FolegattiP.M. AleyP.K. AngusB. BaillieV.L. BarnabasS.L. BhoratQ.E. BibiS. BrinerC. CicconiP. CollinsA.M. Colin-JonesR. CutlandC.L. DartonT.C. DhedaK. DuncanC.J.A. EmaryK.R.W. EwerK.J. FairlieL. FaustS.N. FengS. FerreiraD.M. FinnA. GoodmanA.L. GreenC.M. GreenC.A. HeathP.T. HillC. HillH. HirschI. HodgsonS.H.C. IzuA. JacksonS. JenkinD. JoeC.C.D. KerridgeS. KoenA. KwatraG. LazarusR. LawrieA.M. LelliottA. LibriV. LillieP.J. MalloryR. MendesA.V.A. MilanE.P. MinassianA.M. McGregorA. MorrisonH. MujadidiY.F. NanaA. O’ReillyP.J. PadayacheeS.D. PittellaA. PlestedE. PollockK.M. RamasamyM.N. RheadS. SchwarzboldA.V. SinghN. SmithA. SongR. SnapeM.D. SprinzE. SutherlandR.K. TarrantR. ThomsonE.C. TörökM.E. ToshnerM. TurnerD.P.J. VekemansJ. VillafanaT.L. WatsonM.E.E. WilliamsC.J. DouglasA.D. HillA.V.S. LambeT. GilbertS.C. PollardA.J. AbanM. AbayomiF. AbeyskeraK. AboagyeJ. AdamM. AdamsK. AdamsonJ. AdelajaY.A. AdewetanG. AdlouS. AhmedK. AkhalwayaY. AkhalwayaS. AlcockA. AliA. AllenE.R. AllenL. AlmeidaT.C.D.S.C. AlvesM.P.S. AmorimF. AndritsouF. AnslowR. ApplebyM. Arbe-BarnesE.H. AriaansM.P. ArnsB. ArrudaL. AziP. AziL. BabbageG. BaileyC. BakerK.F. BakerM. BakerN. BakerP. BaldwinL. BaleanuI. BandeiraD. BaraA. BarbosaM.A.S. BarkerD. BarlowG.D. BarnesE. BarrA.S. BarrettJ.R. BarrettJ. BatesL. BattenA. BeadonK. BealesE. BeckleyR. Belij-RammerstorferS. BellJ. BellamyD. BelleiN. BeltonS. BergA. BermejoL. BerrieE. BerryL. BerzenyiD. BeveridgeA. BewleyK.R. BexhellH. BhikhaS. BhoratA.E. BhoratZ.E. BijkerE. BirchG. BirchS. BirdA. BirdO. BisnauthsingK. BittayeM. BlackstoneK. BlackwellL. BletchlyH. BlundellC.L. BlundellS.R. BodaliaP. BoettgerB.C. BolamE. BolandE. BormansD. BorthwickN. BowringF. BoydA. BradleyP. BrennerT. BrownP. BrownC. Brown-O’SullivanC. BruceS. BruntE. BuchanR. BuddW. BulbuliaY.A. BullM. BurbageJ. BurhanH. BurnA. ButtigiegK.R. ByardN. Cabera PuigI. CalderonG. CalvertA. CamaraS. CaoM. CappucciniF. CardosoJ.R. CarrM. CarrollM.W. Carson-StevensA. CarvalhoY.M. CarvalhoJ.A.M. CaseyH.R. CashenP. CastroT. CastroL.C. CathieK. CaveyA. Cerbino-NetoJ. ChadwickJ. ChapmanD. CharltonS. ChelyshevaI. ChesterO. ChitaS. ChoJ-S. CifuentesL. ClarkE. ClarkM. ClarkeA. ClutterbuckE.A. CollinsS.L.K. ConlonC.P. ConnartyS. CoombesN. CooperC. CooperR. CornelissenL. CorrahT. CosgroveC. CoxT. CrockerW.E.M. CrosbieS. CullenL. CullenD. CunhaD.R.M.F. CunninghamC. CuthbertsonF.C. Da GuardaS.N.F. da SilvaL.P. DamratoskiB.E. DanosZ. DantasM.T.D.C. DarrochP. DatooM.S. DattaC. DavidsM. DaviesS.L. DaviesH. DavisE. DavisJ. DavisJ. De NobregaM.M.D. De Oliveira KalidL.M. DearloveD. DemissieT. DesaiA. Di MarcoS. Di MasoC. DinelliM.I.S. DineshT. DockseyC. DoldC. DongT. DonnellanF.R. Dos SantosT. dos SantosT.G. Dos SantosE.P. DouglasN. DowningC. DrakeJ. Drake-BrockmanR. DriverK. DruryR. DunachieS.J. DurhamB.S. DutraL. EasomN.J.W. van EckS. EdwardsM. EdwardsN.J. El MuhannaO.M. EliasS.C. ElmoreM. EnglishM. EsmailA. EssackY.M. FarmerE. FarooqM. FarrarM. FarrugiaL. FaulknerB. FedosyukS. FelleS. FengS. Ferreira Da SilvaC. FieldS. FisherR. FlaxmanA. FletcherJ. FofieH. FokH. FordK.J. FowlerJ. FraimanP.H.A. FrancisE. FrancoM.M. FraterJ. FreireM.S.M. FryS.H. FudgeS. FurzeJ. FuskovaM. Galian-RubioP. GalizaE. GarlantH. GavrilaM. GeddesA. GibbonsK.A. GilbrideC. GillH. GlynnS. GodwinK. GokaniK. GoldoniU.C. GoncalvesM. GonzalezI.G.S. GoodwinJ. GoondiwalaA. Gordon-QuayleK. GoriniG. GrabJ. GracieL. GreenlandM. GreenwoodN. GreffrathJ. GroenewaldM.M. GrossiL. GuptaG. HackettM. HallisB. HamalubaM. HamiltonE. HamlynJ. HammersleyD. HanrathA.T. HanumunthaduB. HarrisS.A. HarrisC. HarrisT. HarrisonT.D. HarrisonD. HartT.C. HartnellB. HassanS. HaughneyJ. HawkinsS. HayJ. HeadI. HenryJ. Hermosin HerreraM. HettleD.B. HillJ. HodgesG. HorneE. HouM.M. HoulihanC. HoweE. HowellN. HumphreysJ. HumphriesH.E. HurleyK. HusonC. Hyder-WrightA. HyamsC. IkramS. IshwarbhaiA. IvanM. IvesonP. IyerV. JacksonF. De JagerJ. JaumdallyS. JeffersH. JesudasonN. JonesB. JonesK. JonesE. JonesC. JorgeM.R. JoseA. JoshiA. JúniorE.A.M.S. KadziolaJ. KailathR. KanaF. KarampatsasK. KasanyingaM. KeenJ. KellyE.J. KellyD.M. KellyD. KellyS. KerrD. KfouriR.Á. KhanL. KhozoeeB. KiddS. KillenA. KinchJ. KinchP. KingL.D.W. KingT.B. KinghamL. KlenermanP. KnapperF. KnightJ.C. KnottD. KolevaS. LangM. LangG. LarkworthyC.W. LarwoodJ.P.J. LawR. LazarusE.M. LeachA. LeesE.A. LemmN-M. LessaA. LeungS. LiY. LiasA.M. LiatsikosK. LinderA. LipworthS. LiuS. LiuX. LloydA. LloydS. LoewL. Lopez RamonR. LoraL. LowthorpeV. LuzK. MacDonaldJ.C. MacGregorG. MadhavanM. MainwaringD.O. MakambwaE. MakinsonR. MalahlehaM. MalamatshoR. MallettG. MansattaK. MaokoT. MapetlaK. MarchevskyN.G. MarinouS. MarlowE. MarquesG.N. MarriottP. MarshallR.P. MarshallJ.L. MartinsF.J. MasenyaM. MasilelaM. MastersS.K. MathewM. MatlebjaneH. MatshidisoK. MazurO. MazzellaA. McCaughanH. McEwanJ. McGlashanJ. McInroyL. McIntyreZ. McLenaghanD. McRobertN. McSwigganS. MegsonC. MehdipourS. MeijsW. MendonçaR.N.Á. MentzerA.J. MirtorabiN. MittonC. MnyakeniS. MoghaddasF. MolapoK. MoloiM. MooreM. Moraes-PintoM.I. MoranM. MoreyE. MorgansR. MorrisS. MorrisS. MorrisH.C. MorselliF. MorsheadG. MorterR. MottalL. MoultrieA. MoyaN. MpelembueM. MsomiS. MugodiY. MukhopadhyayE. MullerJ. MunroA. MunroC. MurphyS. MweuP. MyasakiC.H. NaikG. NakerK. NastouliE. NazirA. NdlovuB. NeffaF. NjengaC. NoalH. NoéA. NovaesG. NugentF.L. NunesG. O’BrienK. O’ConnorD. OdamM. OelofseS. OgutiB. OlchawskiV. OldfieldN.J. OliveiraM.G. OliveiraC. OosthuizenA. O’ReillyP. OsborneP. OwenD.R.J. OwenL. OwensD. OwinoN. PacurarM. PaivaB.V.B. PalharesE.M.F. PalmerS. ParkinsonS. ParrachoH.M.R.T. ParsonsK. PatelD. PatelB. PatelF. PatelK. Patrick-SmithM. PayneR.O. PengY. PennE.J. PenningtonA. Peralta AlvarezM.P. PerringJ. PerryN. PerumalR. PetkarS. PhilipT. PhillipsD.J. PhillipsJ. PhohuM.K. PickupL. PieterseS. PiperJ. PipiniD. PlankM. Du PlessisJ. PollardS. PooleyJ. PooranA. PoultonI. PowersC. PresaF.B. PriceD.A. PriceV. PrimeiraM. ProudP.C. Provstgaard-MorysS. PueschelS. PulidoD. QuaidS. RabaraR. RadfordA. RadiaK. RajapaskaD. RajeswaranT. RamosA.S.F. Ramos LopezF. RamplingT. RandJ. RatcliffeH. RawlinsonT. ReaD. ReesB. ReinéJ. Resuello-DautiM. Reyes PabonE. RibieroC.M. RicamaraM. RichterA. RitchieN. RitchieA.J. RobbinsA.J. RobertsH. RobinsonR.E. RobinsonH. RocchettiT.T. RochaB.P. RocheS. RollierC. RoseL. Ross RussellA.L. RossouwL. RoyalS. RudiansyahI. RuizS. SaichS. SalaC. SaleJ. SalmanA.M. SalvadorN. SalvadorS. SampaioM. SamsonA.D. Sanchez-GonzalezA. SandersH. SandersK. SantosE. Santos GuerraM.F.S. SattiI. SaundersJ.E. SaundersC. SayedA. Schim van der LoeffI. SchmidA.B. SchofieldE. ScreatonG. SeddiqiS. SegireddyR.R. SengerR. SerranoS. ShahR. ShaikI. SharpeH.E. SharrocksK. ShawR. SheaA. ShepherdA. ShepherdJ.G. ShihamF. SidhomE. SilkS.E. da Silva MoraesA.C. Silva-JuniorG. Silva-ReyesL. SilveiraA.D. SilveiraM.B.V. SinhaJ. SkellyD.T. SmithD.C. SmithN. SmithH.E. SmithD.J. SmithC.C. SoaresA. SoaresT. SolórzanoC. SorioG.L. SorleyK. Sosa-RodriguezT. SouzaC.M.C.D.L. SouzaB.S.D.F. SouzaA.R. SpencerA.J. SpinaF. SpoorsL. StaffordL. StamfordI. StarinskijI. SteinR. StevenJ. StockdaleL. StockwellL.V. StricklandL.H. StuartA.C. SturdyA. SuttonN. SzigetiA. Tahiri-AlaouiA. TannerR. TaoushanisC. TarrA.W. TaylorK. TaylorU. TaylorI.J. TaylorJ. te Water NaudeR. ThemistocleousY. ThemistocleousA. ThomasM. ThomasK. ThomasT.M. ThombrayilA. ThompsonF. ThompsonA. ThompsonK. ThompsonA. ThomsonJ. Thornton-JonesV. TigheP.J. TinocoL.A. TiongsonG. TladinyaneB. TomasicchioM. TomicA. TonksS. TownerJ. TranN. TreeJ. TrillanaG. TrinhamC. TrivettR. TrubyA. TshekoB.L. TurabiA. TurnerR. TurnerC. UlaszewskaM. UnderwoodB.R. VarugheseR. VerbartD. VerheulM. VichosI. VieiraT. WaddingtonC.S. WalkerL. WallisE. WandM. WarbickD. WardellT. WarimweG. WarrenS.C. WatkinsB. WatsonE. WebbS. Webb-BridgesA. WebsterA. WelchJ. WellsJ. WestA. WhiteC. WhiteR. WilliamsP. WilliamsR.L. WinslowR. WoodyerM. WorthA.T. WrightD. WroblewskaM. YaoA. ZimmerR. ZiziD. ZuidewindP. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.Lancet2021397102699911110.1016/S0140‑6736(20)32661‑133306989
     [Google Scholar]
  17. TenfordeM.W. SelfW.H. AdamsK. GaglaniM. GindeA.A. McNealT. GhamandeS. DouinD.J. TalbotH.K. CaseyJ.D. MohrN.M. ZepeskiA. ShapiroN.I. GibbsK.W. FilesD.C. HagerD.N. ShehuA. PrekkerM.E. EricksonH.L. ExlineM.C. GongM.N. MohamedA. HenningD.J. SteingrubJ.S. PeltanI.D. BrownS.M. MartinE.T. MontoA.S. KhanA. HoughC.L. BusseL.W. ten LohuisC.C. DuggalA. WilsonJ.G. GordonA.J. QadirN. ChangS.Y. MallowC. RivasC. BabcockH.M. KwonJ.H. HalasaN. ChappellJ.D. LauringA.S. GrijalvaC.G. RiceT.W. JonesI.D. StubblefieldW.B. BaughmanA. WomackK.N. RhoadsJ.P. LindsellC.J. HartK.W. ZhuY. OlsonS.M. KobayashiM. VeraniJ.R. PatelM.M. Association between mRNA vaccination and COVID-19 hospitalization and disease severity.JAMA2021326202043205410.1001/jama.2021.1949934734975
     [Google Scholar]
  18. DaganN. BardaN. KeptenE. MironO. PerchikS. KatzM.A. HernánM.A. LipsitchM. ReisB. BalicerR.D. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.N. Engl. J. Med.2021384151412142310.1056/NEJMoa210176533626250
     [Google Scholar]
  19. IsraelA. ShenharY. GreenI. MerzonE. Golan-CohenA. SchäfferA.A. RuppinE. VinkerS. MagenE. Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection.Vaccines20211016410.3390/vaccines1001006435062724
     [Google Scholar]
  20. GrasseM. MerykA. SchirmerM. Grubeck-LoebensteinB. WeinbergerB. Booster vaccination against tetanus and diphtheria: Insufficient protection against diphtheria in young and elderly adults.Immun. Ageing20161312610.1186/s12979‑016‑0081‑027602049
     [Google Scholar]
  21. PileggiC. PapadopoliR. BiancoA. PaviaM. Hepatitis B vaccine and the need for a booster dose after primary vaccination.Vaccine201735466302630710.1016/j.vaccine.2017.09.07628988867
     [Google Scholar]
  22. Institut RKEpidemiologisches Bulletin.2021Available from:https://api.blaek.de/content/medien/z8m3fh73jn1538047584flsqws6t0n920/9vksypq3d91648122957houhcqtfgx261/stiko_empfehlungen_epibull-04_22.cleaned.pdf
  23. LeeA.R.Y.B. WongS.Y. ChaiL.Y.A. LeeS.C. LeeM.X. MuthiahM.D. TayS.H. TeoC.B. TanB.K.J. ChanY.H. SundarR. SoonY.Y. Efficacy of covid-19 vaccines in immunocompromised patients: Systematic review and meta-analysis.BMJ2022376e06863210.1136/bmj‑2021‑06863235236664
     [Google Scholar]
  24. FerriC. RaimondoV. GiuggioliD. GragnaniL. LoriniS. DagnaL. BoselloS.L. FotiR. RiccieriV. GuiducciS. CuomoG. TavoniA. De AngelisR. CacciapagliaF. ZanattaE. CozziF. MurdacaG. CavazzanaI. RomeoN. CodulloV. PellegriniR. VarcasiaG. De SantisM. SelmiC. AbignanoG. CaminitiM. L’AndolinaM. OlivoD. LubranoE. SpinellaA. LumettiF. De LucaG. RuscittiP. UrraroT. VisentiniM. Bellando-RandoneS. VisalliE. TestaD. SciasciaG. MasiniF. PellegrinoG. SacconF. BalestriE. EliaG. FerrariS.M. TonuttiA. Dall’AraF. Pagano MarianoG. PettitiG. ZanframundoG. BrittelliR. AielloV. Dal BoscoY. FotiR. Di ColaI. ScorpinitiD. FusaroE. FerrariT. GigliottiP. CampochiaroC. FranciosoF. IandoliC. CairaV. ZignegoA.L. D’AngeloS. FranceschiniF. Matucci-CerinicM. GiacomelliR. DoriaA. SantiniS.A. FallahiP. IannoneF. AntonelliA. Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase.J. Transl. Autoimmun.2023710021210.1016/j.jtauto.2023.10021237854035
     [Google Scholar]
  25. ZimmermannP. CurtisN. Factors that influence the immune response to vaccination.Clin. Microbiol. Rev.2019322e00084-1810.1128/CMR.00084‑1830867162
     [Google Scholar]
  26. HaqueA. PantA.B. Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy.J. Autoimmun.202212710279210.1016/j.jaut.2021.10279234995958
     [Google Scholar]
  27. DhawanM. SaiedA.A. MitraS. AlhumaydhiF.A. EmranT.B. WilairatanaP. Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?Biomed. Pharmacother.202215411352210.1016/j.biopha.2022.11352236030585
     [Google Scholar]
  28. World Health OrganizationCoronavirus disease (COVID-19): Vaccines and vaccine safety: World Health Organization.2023Available from:https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-(covid-19)-vaccines?adgroupsurvey={adgroupsurvey}&gclid=EAIaIQobChMIls_WzaCp_QIVA_l3Ch2nPgQPEAAYAiAAEgJmNPD_BwE (Accessed on: 2023-11-27).
  29. MalikJ.A. AhmedS. MirA. ShindeM. BenderO. AlshammariF. AnsariM. AnwarS. The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges.J. Infect. Public Health202215222824010.1016/j.jiph.2021.12.01435042059
     [Google Scholar]
  30. World Health OrganizationClassification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern 2023.2023Available from:https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern (Accessed on: 2023-11-27).
  31. Centers for Disease Control and PreventionCOVID-19 - Variants of the Virus: Centers for Disease Control and Prevention.2023Available from:https://www.cdc.gov/coronavirus/2019-ncov/variants/index.html (Accessed on: 2023-11-27).
  32. KumarS. ThambirajaT.S. KaruppananK. SubramaniamG. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.J. Med. Virol.20229441641164910.1002/jmv.2752634914115
     [Google Scholar]
  33. LipsitchM. KrammerF. Regev-YochayG. LustigY. BalicerR.D. SARS-CoV-2 breakthrough infections in vaccinated individuals: Measurement, causes and impact.Nat. Rev. Immunol.2022221576510.1038/s41577‑021‑00662‑434876702
     [Google Scholar]
  34. GriffinJ.B. HaddixM. DanzaP. FisherR. KooT.H. TraubE. GounderP. JarashowC. BalterS. SARS-CoV-2 infections and hospitalizations among persons Aged ≥16 Years, by vaccination status — los angeles county, California, May 1–July 25, 2021.MMWR Morb. Mortal. Wkly. Rep.202170341170117610.15585/mmwr.mm7034e534437525
     [Google Scholar]
  35. ZaeckL.M. GeurtsvanKesselC.H. de VriesR.D. COVID-19 vaccine effectiveness and evolving variants: Understanding the immunological footprint.Lancet Respir. Med.202311539539610.1016/S2213‑2600(23)00140‑637080227
     [Google Scholar]
  36. LubkeN SenffT SchergerS HaukaS AndreeM AdamsO Extraction-free SARS-CoV-2 detection by rapid RT-qPCR universal for all primary respiratory materials.J Clin Virol 2020130104579
     [Google Scholar]
  37. WalkerA HouwaartT WienemannT VasconcelosMK StrelowD SenffT Genetic structure of SARS-CoV-2 reflects clonal superspreading and multiple independent introduction events, North-Rhine Westphalia, Germany.Euro Surveill202025(22)
     [Google Scholar]
  38. OoiG.C. KhongP.L. MüllerN.L. YiuW.C. ZhouL.J. HoJ.C.M. LamB. NicolaouS. TsangK.W.T. Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients.Radiology2004230383684410.1148/radiol.230303085314990845
     [Google Scholar]
  39. CocconcelliE. BiondiniD. GiraudoC. LococoS. BernardinelloN. FicheraG. BarbieroG. CastelliG. CavinatoS. FerrariA. SaettaM. CattelanA. SpagnoloP. BalestroE. Clinical features and chest imaging as predictors of intensity of care in patients with COVID-19.J. Clin. Med.202099299010.3390/jcm909299032947904
     [Google Scholar]
  40. GiraudoC. CavaliereA. FicheraG. WeberM. MottaR. PellosoM. TosatoF. LupiA. CalabreseF. CarrettaG. CattelanA.M. De ContiG. CianciV. NavalesiP. PlebaniM. ReaF. VettorR. VianelloA. StramareR. Validation of a composed COVID-19 chest radiography score: The CARE project.ERJ Open Res.20206400359-202010.1183/23120541.00359‑202033263058
     [Google Scholar]
  41. BorghesiA. MaroldiR. COVID-19 outbreak in Italy: Experimental chest x-ray scoring system for quantifying and monitoring disease progression.Radiol. Med.2020125550951310.1007/s11547‑020‑01200‑332358689
     [Google Scholar]
  42. BorghesiA. ZiglianiA. GolemiS. CarapellaN. MaculottiP. FarinaD. MaroldiR. Chest x-ray severity index as a predictor of in-hospital mortality in coronavirus disease 2019: A study of 302 patients from Italy.Int. J. Infect. Dis.20209629129310.1016/j.ijid.2020.05.02132437939
     [Google Scholar]
  43. Abu-RaddadL.J. ChemaitellyH. AyoubH.H. AlMukdadS. YassineH.M. Al-KhatibH.A. SmattiM.K. TangP. HasanM.R. CoyleP. Al-KanaaniZ. Al-KuwariE. JeremijenkoA. KaleeckalA.H. LatifA.N. ShaikR.M. Abdul-RahimH.F. NasrallahG.K. Al-KuwariM.G. ButtA.A. Al-RomaihiH.E. Al-ThaniM.H. Al-KhalA. BertolliniR. Effect of mRNA vaccine boosters against SARS-CoV-2 omicron infection in Qatar.N. Engl. J. Med.2022386191804181610.1056/NEJMoa220079735263534
     [Google Scholar]
  44. UzunO. AkpolatT. VarolA. TuranS. BektasS.G. CetinkayaP.D. DursunM. BakanN. KetenciogluB.B. BayrakM. BarisS.A. GunerR. GunalO. NuralS. DenizP.P. ToprakO.B. OzkanG. GumusA. KergetF. ErcelikM. AtaogluO. YukselA. AtesG. KutsoyluO.E. KoseN. KizilirmakD. KeskinS. GultekinO. CoskunN. YilmazE.S. UsluS. Basyigitİ. ErganB. DeveciF. YakarM.N. ZuhurC. SagcanG. YuceZ.T. KuluozturkM. SezginM.E. SezginE.N.A. HavlucuY. CuhadarogluC. KilincO. BoyaciH. AltunayH. AktiM. DursunZ.B. KalemA.K. IsikS.A. AkyildizL. AykacN. AlmazM.S. KokturkN. ItilO. COVID-19: Vaccination vs. hospitalization.Infection202250374775210.1007/s15010‑021‑01751‑134984646
     [Google Scholar]
  45. HtayH. FooM.W.Y. JayaballaM. JohnsonD.W. OeiE.L. TanB.H. WangW. WuS.Y. TanC.S. Clinical features, management and outcomes of peritoneal dialysis patients during Delta and Omicron waves of COVID-19 infections.Int. Urol. Nephrol.20235582075208110.1007/s11255‑023‑03496‑236820945
     [Google Scholar]
  46. European Centre for Disease Prevention and ControlCOVID-19 Vaccine Tracker: European Centre for Disease Prevention and Control.2023Available from:https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#uptake-tab (Accessed on: 2023-11-27).
  47. Centers for Disease Control and PreventionCOVID Data Tracker - COVID-19 Vaccinations in the United States: Centers for Disease Control and Prevention.2023Available from:https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-total-admin-rate-total (Accessed on: 2023-11-27).
  48. ShahidZ. KalayanamitraR. McClaffertyB. KepkoD. RamgobinD. PatelR. AggarwalC.S. VunnamR. SahuN. BhattD. JonesK. GolamariR. JainR. COVID-19 and Older Adults: What We Know.J. Am. Geriatr. Soc.202068592692910.1111/jgs.1647232255507
     [Google Scholar]
  49. PijlsB.G. JolaniS. AtherleyA. DerckxR.T. DijkstraJ.I.R. FranssenG.H.L. HendriksS. RichtersA. Venemans-JellemaA. ZalpuriS. ZeegersM.P. Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies.BMJ Open2021111e04464010.1136/bmjopen‑2020‑04464033431495
     [Google Scholar]
  50. Doncheva - DilovaJ.S. BoyadzhievaV. StoilovN. Clinical and immune-related manifestations in patients with COVID-19.Rheumatology2023311549410.35465/31.1.2023.pp54‑94
     [Google Scholar]
  51. LeeJ.E. HwangM. KimY.H. ChungM.J. SimB.H. ChaeK.J. YooJ.Y. JeongY.J. Imaging and clinical features of COVID-19 breakthrough infections: A multicenter study.Radiology2022303368269210.1148/radiol.21307235103535
     [Google Scholar]
  52. VasileiouE. SimpsonC.R. ShiT. KerrS. AgrawalU. AkbariA. BedstonS. BeggsJ. BradleyD. ChuterA. de LusignanS. DochertyA.B. FordD. HobbsF.D.R. JoyM. KatikireddiS.V. MarpleJ. McCowanC. McGaghD. McMenaminJ. MooreE. MurrayJ.L.K. PanJ. RitchieL. ShahS.A. StockS. TorabiF. TsangR.S.M. WoodR. WoolhouseM. RobertsonC. SheikhA. Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: A national prospective cohort study.Lancet2021397102851646165710.1016/S0140‑6736(21)00677‑233901420
     [Google Scholar]
  53. MyersL.C. KipnisP. GreeneJ. LawsonB. EscobarG.J. FiremanB.H. KleinN.P. LiuV.X. Adults hospitalized with breakthrough COVID-19 have lower mortality than matched unvaccinated adults.J. Intern. Med.2022292237738410.1111/joim.1350435531712
     [Google Scholar]
  54. MirouseA. FriolA. MoreauA.S. JungB. JullienE. BureauC. DjibréM. de ProstN. ZafraniL. ArgaudL. ReuterD. CalvetL. de MontmollinE. BenghanemS. PichereauC. PhamT. CacoubP. BiardL. SaadounD. Severe SARS-Cov2 pneumonia in vaccinated patients: A multicenter cohort study.Sci. Rep.2023131190210.1038/s41598‑023‑29131‑936732353
     [Google Scholar]
  55. Bundesministerium für GesundheitCOVID-19 Impfdashboard: Bundesministerium für Gesundheit.2023Available from:https://impfdashboard.de/daten (Accessed on: 2023-11-27).
  56. Ravindra NaikB. Anil KumarS. RachegowdaN. Yashas UllasL. RevanthR.B. Venkata Sai AluruN.R. Severity of COVID-19 infection using chest computed tomography severity score index among vaccinated and unvaccinated COVID-19-positive healthcare workers: An analytical cross-sectional study.Cureus2022142e2208710.7759/cureus.2208735295366
     [Google Scholar]
  57. JuthaniP.V. GuptaA. BorgesK.A. PriceC.C. LeeA.I. WonC.H. ChunH.J. Hospitalisation among vaccine breakthrough COVID-19 infections.Lancet Infect. Dis.202121111485148610.1016/S1473‑3099(21)00558‑234506735
     [Google Scholar]
  58. MahmoudM. CarmiscianoL. TagliaficoL. MuzykaM. RosaG. SignoriA. BassettiM. NencioniA. MonacelliF. Patterns of comorbidity and in-hospital mortality in older patients with COVID-19 infection.Front. Med.2021872683710.3389/fmed.2021.72683734604262
     [Google Scholar]
  59. Al-SabahS. Al-HaddadM. Al-YouhaS. JamalM. AlmazeediS. COVID-19: Impact of obesity and diabetes on disease severity.Clin. Obes.2020106e1241410.1111/cob.1241433079448
     [Google Scholar]
  60. van den BergJ.M. RemmelzwaalS. BlomM.T. van HoekB.A.C.E. SwartK.M.A. OverbeekJ.A. BurchellG.L. HeringsR.M.C. EldersP.J.M. Effectiveness of COVID-19 vaccines in adults with diabetes mellitus: A systematic review.Vaccines20221112410.3390/vaccines1101002436679869
     [Google Scholar]
  61. SunJ. ZhengQ. MadhiraV. OlexA.L. AnzaloneA.J. VinsonA. SinghJ.A. FrenchE. AbrahamA.G. MathewJ. SafdarN. AgarwalG. FitzgeraldK.C. SinghN. TopalogluU. ChuteC.G. MannonR.B. KirkG.D. PatelR.C. SafoS. PatchD.A. HaendelM.A. IslamJ.Y. AkselrodH. FranceschiniN. ChiangT.P. BhattacharyyaS. BramanteC. DuongT. ChirischillesE.A. Association between immune dysfunction and COVID-19 breakthrough infection after SARS-CoV-2 vaccination in the US.JAMA Intern. Med.2022182215316210.1001/jamainternmed.2021.702434962505
     [Google Scholar]
  62. SchmidtA.L. LabakiC. HsuC.Y. BakounyZ. BalanchivadzeN. BergS.A. BlauS. DaherA. El ZarifT. FrieseC.R. GriffithsE.A. HawleyJ.E. Hayes-LattinB. KariveduV. LatifT. MavromatisB.H. McKayR.R. NagarajG. NguyenR.H. PanagiotouO.A. PortugueseA.J. PucM. Santos DutraM. SchroederB.A. ThakkarA. Wulff-BurchfieldE.M. MishraS. FarmakiotisD. ShyrY. WarnerJ.L. ChoueiriT.K. ChoueiriT.K. DumaN. FarmakiotisD. GrivasP. de Lima LopesG.Jr PainterC.A. PetersS. RiniB.I. ShahD.P. ThompsonM.A. WarnerJ.L. COVID-19 vaccination and breakthrough infections in patients with cancer.Ann. Oncol.202233334034610.1016/j.annonc.2021.12.00634958894
     [Google Scholar]
  63. SuleymanG. FadelR. BrarI. KassabR. KhansaR. SturlaN. AlsaadiA. LatackK. MillerJ. TibbettsR. SamuelL. AlangadenG. RameshM. Risk factors associated with hospitalization and death in COVID-19 breakthrough infections.Open Forum Infect. Dis.202295ofac11610.1093/ofid/ofac11635437511
     [Google Scholar]
  64. CocciaM. Sources, diffusion and prediction in COVID-19 pandemic: Lessons learned to face next health emergency.AIMS Public Health202310114516810.3934/publichealth.202301237063362
     [Google Scholar]
  65. GkoutzourelasA. BogdanosD.P. SakkasL.I. Kawasaki disease and COVID-19.Mediterr. J. Rheumatol.202031Suppl. 226827410.31138/mjr.31.3.26833196004
     [Google Scholar]
  66. RadtkeR. Impfungen gegen das Coronavirus (COVID-19) in Deutschland nach Hersteller.2021Available from:https://de.statista.com/statistik/daten/studie/1197550/umfrage/impfungen-gegen-das-coronavirus-nach-hersteller/
  67. MenniC. ValdesA.M. PolidoriL. AntonelliM. PenamakuriS. NogalA. LoucaP. MayA. FigueiredoJ.C. HuC. MolteniE. CanasL. ÖsterdahlM.F. ModatM. SudreC.H. FoxB. HammersA. WolfJ. CapdevilaJ. ChanA.T. DavidS.P. StevesC.J. OurselinS. SpectorT.D. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: A prospective observational study from the ZOE COVID Study.Lancet2022399103351618162410.1016/S0140‑6736(22)00327‑035397851
     [Google Scholar]
  68. WrennJ.O. PakalaS.B. VestalG. ShiltsM.H. BrownH.M. BowenS.M. StricklandB.A. WilliamsT. MallalS.A. JonesI.D. SchmitzJ.E. SelfW.H. DasS.R. COVID-19 severity from omicron and delta SARS-CoV-2 variants.Influenza Other Respir. Viruses202216583283610.1111/irv.1298235415869
     [Google Scholar]
/content/journals/cmir/10.2174/0115734056282920231212104602
Loading
Disease Course and Pulmonary Involvement of COVID-19 during the Delta Variant Period in Germany: A Comparative Study of Vaccinated and Unvaccinated Patients at a Tertiary Hospital
Curr. Med. Imaging 20, e15734056282920 (2024); https://doi.org/10.2174/0115734056282920231212104602
/content/journals/cmir/10.2174/0115734056282920231212104602
/content/journals/cmir/10.2174/0115734056282920231212104602
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): ARDS; COVID-19; CT; Genome sequencing; Viral infection; X-ray

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test